Immunogenicity of Anti-TNF-α Biotherapies: I. Individualized Medicine Based on Immunopharmacological Evidence.
about
Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune ComplexesRecent Advances in Application of Pharmacogenomics for BiotherapeuticsSecukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity.Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events.Insights on the use of biosimilars in the treatment of inflammatory bowel disease.Current and novel anti-inflammatory drug targets for inhibition of cytokines and leucocyte recruitment in rheumatic diseases.Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?
P2860
Q26766424-D509CBDC-403A-4D92-A092-B6C2CAC4F503Q29247996-943B8CBE-8F6D-4CC7-BCD3-0C2869AEF5E7Q37138974-E8CFF007-0C7F-4377-B8CC-0063CAB33C4DQ38643965-9C4AB7A6-93A7-4C8E-B2BF-3D5289041C77Q38735477-B9CEB3B5-3FEC-4791-B86F-0D7C01169B9DQ48129259-43BB9422-F4C9-4EBD-BDCB-8D7C8D718FDEQ51397182-BBFD9F7D-9451-4319-819E-5A91CAB820B0
P2860
Immunogenicity of Anti-TNF-α Biotherapies: I. Individualized Medicine Based on Immunopharmacological Evidence.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunogenicity of Anti-TNF-α B ...... mmunopharmacological Evidence.
@en
type
label
Immunogenicity of Anti-TNF-α B ...... mmunopharmacological Evidence.
@en
prefLabel
Immunogenicity of Anti-TNF-α B ...... mmunopharmacological Evidence.
@en
P2860
P356
P1476
Immunogenicity of Anti-TNF-α B ...... mmunopharmacological Evidence.
@en
P2093
Klaus Bendtzen
P2860
P356
10.3389/FIMMU.2015.00152
P577
2015-04-08T00:00:00Z